Probably because of the explosion of ultraendurance running participation, a large amount of research on the physiological consequences of ultramarathons has been conducted recently (7,25,31,33). This type of event permits the investigation and greater understanding of the limits of human performance (28). The origins of fatigue are dependent on numerous factors, including the type of exercise, making the ultratrail running subgroup of endurance-running a unique field of study. With substantial elevation change and long duration, ultratrails combine a range of exercise intensities and use various muscle groups, activation patterns, and types of muscle contraction (i.e., combining concentric and severe eccentric loads).
Neuromuscular fatigue is an exercise-related decrease in the maximal voluntary torque of a muscle or muscle group, regardless of whether or not a task can be sustained (2). This may involve processes at all levels of the motor pathway from the brain to the skeletal muscle. Large central fatigue (i.e., reduced maximal voluntary activation) has been observed in running bouts longer than 5 h (25,31,33,37). The presence of central fatigue does not mean an absence of peripheral fatigue, although compared with the central component, peripheral fatigue appears to be only of moderate importance in extremely long-duration exercise. Only a few studies have investigated central fatigue in running exercise longer than 12 h in duration (25,33,40), and only two have combined elevation change and extreme duration (33,40). All these studies used the classic peripheral electrical stimulation techniques of twitch interpolation and central activation ratio to assess voluntary activation (27). The major issue with these techniques is that they do not permit the differentiation between spinal and supraspinal components of central fatigue.
Using transcranial magnetic stimulation (TMS) in parallel with peripheral nerve stimulation during voluntary isometric contractions, Gandevia et al. (9) observed that as exercise duration increases, the role of supraspinal factors in fatigue increases and that supraspinal deficits and failure are not necessarily paralleled by impairment of motor cortical excitability. Furthermore, the presence of central fatigue does not mean that both spinal and supraspinal fatigue are certainties.
Dynamic whole-body exercise has only recently been investigated with TMS, predominantly in cycling studies (e.g., 11,44,50). Only one published study has used TMS with running (39), observing decreased cortical voluntary activation of the dorsiflexors after a treadmill marathon. This study also observed decreased motor-evoked potential (MEP) amplitude of the tibialis anterior in relaxed muscle immediately after marathon; however, MEP amplitude assessed in relaxed muscle limits interpretation because of both the greater MEP variability and lower corticospinal excitability in the relaxed muscle state (14). All other whole-body investigations of voluntary activation assessed by TMS (VATMS) have been conducted with cycling and generally showed decreased VATMS when evaluated 2–4 min after exercise (11,43,50), although not 10 min after ∼1.5 h of cycling (21). The inconsistent changes in VATMS after exercise may be due to the variable delay to postexercise measures and/or differences in exercise intensity and/or duration.
At similar exercise intensities, there is less central fatigue in cycling than running (24,37), and this has been proposed to be related to increased influence of group III/IV afferents because of increased muscle damage in running (30). Unlike the dorsiflexors, which do not limit running performance (8), and plantar flexors, which display only moderate central deficits, the knee extensors demonstrate large central deficits after prolonged exercise (25,33). Whether this manifests at the supraspinal level in trail running, particularly given the muscle damage associated with the eccentric nature of downhill running, remains to be determined. The use of TMS in parallel with peripheral nerve stimulation can provide greater insight into the source of these central changes. These two techniques used to investigate central deficits provide different mechanistic insights. An increase in the evoked response to peripheral nerve stimulation indicates derecruitment or decreased motoneuron firing. Meanwhile, an increase in the mechanical response to TMS demonstrates that the limiting factor is not due to an inability of the upper motoneurons to respond to increased motor input.
Despite large central consequences, the effects of long running bouts on supraspinal activity and any subsequent effect on knee extensor function are unknown. Specifically, whether a supraspinal deficit occurs with an ultraendurance trail-running race and whether or not any such deficit is associated with changes in corticospinal excitability and/or intracortical inhibition remain to be determined. The aim of this study was thus to test the hypotheses that (i) an ultratrail decreases VATMS and (ii) corticospinal fatigue occurs despite no change or increased MEP amplitude and unchanged cortical silent period (CSP).
Thirty-five healthy experienced ultraendurance trail runners (15 females and 20 males) were recruited to participate in this study. Six subjects (three females and three males) did not complete the ultratrail, and three others (one female and two males) did not perform postrace testing due to time constraints. One other subject was only physically capable of completing a small portion of the post-ultratrail evaluations and was subsequently eliminated from analyses. Thus, 25 subjects (11 females and 14 males) participated in all aspects of this study (mean ± SD; age = 43 ± 9 yr, height = 172 ± 8 cm, body mass = 65.4 ± 9.5 kg, maximal oxygen consumption [V˙O2max] = 56.3 ± 6.5 mL·kg−1·min−1). Subjects were informed of the experimental protocol and all associated risks before giving written informed consent as part of a medical inclusion. All procedures conformed to the Declaration of Helsinki and were approved by the local ethics committee. All subjects were experienced ultraendurance trail runners because participation in the partner ultratrail (the North Face®® Ultra-Trail du Mont-Blanc® 2012) required completion of a minimum of two demanding trail-running races with significant elevation change in the 2 yr preceding the race.
Each subject completed one preliminary session and two experimental sessions. During the preliminary session, subjects completed a maximal incremental running test. They were also introduced to all experimental procedures and repeated trials until they were able to perform all tests consistently and as directed. The first experimental session (PRE) occurred on 1 of the 3 d before the North Face® Ultra-Trail du Mont-Blanc® 2012 and the second (POST) 1:01:30 ± 0:22:37 after completing the ultratrail. Because of exceptional inclement weather, the 2012 edition of the North Face® Ultra-Trail du Mont Blanc® involved running/walking 110 km with total positive elevation change of 5862 m (see Figure, Supplemental Digital Content 1, https://links.lww.com/MSS/A392). Under conditions of a mixture of rain, snow and clouds, the temperature reached a maximum of 12°C in Chamonix and decreased lower than 0°C at altitudes higher than 1800 m.
After a medical examination, subjects performed a maximal incremental running test to exhaustion on a treadmill (EF1800; HEF Tecmachine, Andrezieux-Boutheon, France). The subjects began the test at 10% grade and a speed of 4–6 km·h−1, with starting speed corresponding to running ability. The speed was then increased by 1 km·h−1 until volitional exhaustion. Subjects ran 2 min 30 s at each speed and then stopped for 30 s for a blood sample for lactate measurement. Respiratory measures were assessed breath by breath by an online system (Ergocard, Medisoft, Sorinnes, Belgium) and averaged every 30 s. V˙O2max was considered as the oxygen consumption during the last 30 s before exhaustion.
The familiarization portion of the preliminary visit included maximal and submaximal contractions of the knee extensors with and without femoral nerve electrical stimulation (FNES) and TMS (see Neuromuscular Testing Protocol section). For TMS, this included training subjects to return to the prestimulus torque as soon as possible after the stimulus to permit accurate measurement of the CSP.
Neuromuscular Testing Protocol
Neuromuscular measures (Fig. 1) were assessed PRE and POST with real-time visual feedback. Maximal torque was determined from 3 maximal voluntary contractions (MVC) separated by 30 s with FNES (100-Hz paired pulses and single pulses) delivered at peak torque and immediately after in the relaxed state (100-Hz paired pulses and single pulses). Then, three series of four contractions were performed with TMS delivered at the desired torque level (100%, 75%, and 50% MVC at optimal TMS intensity (51) and 50% MVC at suboptimal TMS intensity; for further details, see the following sections). Contractions were separated by 15 s and series by 30 s.
Force and EMG Recordings
Knee extensor force was measured during voluntary and evoked contractions by a calibrated force transducer (Meiri F2732 200 daN; Celians, Montauban, France) with amplifier attached by a noncompliant strap to the right leg just proximal to the malleoli of the ankle joint. Subjects were seated upright in a custom-built chair with both right knee and hips at 90° of flexion. The load cell was fixed to the chair such that force was measured in direct line to the applied force. Torque was calculated as force measured by the force transducer multiplied by the length of the lever arm (i.e., distance from the tibial condyles to where the force transducer was attached to the leg).
EMG activity of the right knee extensors (vastus lateralis [VL]) was recorded with a pair of self-adhesive surface electrodes (Meditrace 100; Covidien, Mansfield, MA) in bipolar configuration with a 30-mm interelectrode distance and the reference on the patella. Low impedance (<5 kΩ) between electrodes was obtained by shaving, gently abrading the skin and then cleaning it with isopropyl alcohol. Signals were converted from analog to digital at a sampling rate of 2000 Hz using PowerLab system (16/30-ML880/P; ADInstruments, Bella Vista, Australia) and octal bio-amplifier (ML138, ADInstruments; common mode rejection ratio = 85 dB, gain = 500) with band-pass filter (5–500 Hz) and analyzed offline using Labchart 7 software (ADInstruments).
Single electrical stimuli of 1-ms duration were delivered via constant-current stimulator (DS7A; Digitimer, Welwyn Garden City, Hertfordshire, UK) to the right femoral nerve via a 30-mm-diameter surface cathode manually pressed into the femoral triangle (Meditrace 100; Covidien) and 50 × 90 mm rectangular anode (Durastick Plus; DJO Global, Vista, CA) in the gluteal fold. Single stimuli were delivered incrementally until maximal M-wave (Mmax) and twitch amplitudes plateaued. Stimulus intensity of 130% of the intensity to produce Mmax and maximal twitch responses was used to confirm supramaximality. Stimulus intensity was determined at the start of each session. Supramaximal FNES intensity increased from PRE (58 ± 16 mA) to POST (65 ± 19 mA) (P = 0.025).
Transcranial Magnetic Stimulation
Single TMS pulses of 1-ms duration were manually delivered to elicit MEP and superimposed twitches (SIT) during voluntary isometric knee extension. The contralateral motor cortex was stimulated by a magnetic stimulator (Magstim 2002, The Magstim Company Ltd., Whitland, UK) with a 110-mm double-cone coil (maximum output of 1.4 T) to induce a posteroanterior current. The coil was manually controlled by an experienced investigator throughout the protocol. Subjects wore a cervical collar during all TMS measures to stabilize the head and neck. Subjects also wore a latex swim cap on which lines were drawn between the preauricular points and from nasion to inion to identify the vertex. Every centimeter was demarcated from the vertex to 2 cm posterior to the vertex along the nasal-inion line and also to 1 cm over the left motor cortex. At each point, a stimulus was delivered at 50% maximal stimulator output during brief voluntary contractions of the knee extensors at 10% MVC torque to determine the optimal stimulus site. The coil was positioned at the site evoking the largest MEP amplitude and SIT throughout the protocol. Stimulus intensity was determined from a stimulus–response curve determined from MEP responses evoked during brief (∼2–3 s) voluntary contractions at 20% MVC. TMS was delivered during two consecutive contractions at each of the randomly ordered stimulus intensities of 40%, 50%, 60%, and 70% maximal stimulator output. Stimuli were delivered at 15-s intervals. Optimal TMS intensity was defined as the lowest stimulus intensity eliciting maximal MEP amplitudes (13). If a plateau was not confirmed from these intensities, higher TMS intensities were investigated. A suboptimal TMS intensity equivalent to 60% of the optimal intensity (i.e., corresponding to the rising part of the MEP stimulus–response curve) was also selected to identify any shift in the stimulus–response curve. Mean TMS intensities PRE were 66% ± 9% and 40% ± 5% maximal stimulator output for optimal and suboptimal TMS intensities, respectively. Coil position in relation to the vertex was noted because identical coil position and TMS intensities were used PRE and POST. Immediately after POST evaluation, optimal TMS intensity was redetermined in subjects still physically capable of sustaining the target torque level (20% MVC POST) (n = 21). Optimal TMS intensity in these subjects was similar PRE and POST (66% ± 9% vs 67% ± 6% maximal stimulator output, respectively; P = 0.54). During voluntary contractions, TMS was always delivered once the subject had contracted to the appropriate torque level and the torque had stabilized. Subjects were also instructed to recontract to the prestimulus torque level immediately after TMS delivery.
EMG and FNES
M-wave peak-to-peak amplitude and duration were calculated from FNES in both relaxed (Mmax) and contracted (Msup at 100% MVC) muscles. Maximal torque was calculated as the mean peak torque from three MVC. EMG root mean square (RMS) was calculated as the mean from three MVC for a 200-ms period after the torque had reached a plateau and before FNES was delivered (RMSMVC). Then, RMSMVC was normalized to both Mmax and Msup. The amplitudes of the potentiated peak twitch (TwPot) and doublet (100-Hz paired pulse, Db100) torques were also determined.
Voluntary activation (VAFNES) was also assessed by twitch interpolation using the superimposed and potentiated doublet amplitudes elicited by 100-Hz FNES paired pulses during and after MVC and calculated from the equation: [1 – (FNES 100-Hz superimposed doublet amplitude)·Db100−1] × 100. Raw traces of the superimposed doublet are presented in Supplemental Digital Content 2 (https://links.lww.com/MSS/A393).
Transcranial magnetic stimulation
The peak-to-peak amplitudes of MEP were measured and normalized to Msup measured at the same time point. VATMS during maximal effort was measured with TMS by modified twitch interpolation. For each series of contractions, estimated resting twitch (ERT) was determined by the linear regression of the relation between SIT amplitude evoked when optimal-intensity TMS was delivered at 100%, 75%, and 50% MVC (see Figure, Supplemental Digital Content 2, https://links.lww.com/MSS/A393) and voluntary torque (12,42,51). This relation was extrapolated, and the y-intercept was interpreted as the ERT amplitude. In cases where the linear regression was not linear (r < 0.9), ERT was excluded and VATMS was not calculated for the series (17). ERT was linear for all subjects for at least one series at both PRE and POST, thus permitting VATMS to be determined in all subjects. VATMS was assessed with the following equation: [1 – (SIT·ERT−1)] × 100. The reliability of this method has recently been validated in the knee extensors (12,42). The duration of the CSP was determined visually and defined as the duration from the stimulus to the return of continuous voluntary EMG (43). Subjects were excluded from CSP analyses if they did not recontract to the prestimulus torque level immediately after delivery of single TMS pulses.
Statistical analyses were performed with Statistica (version 8; StatSoft, Tulsa, OK). The Shapiro–Wilk test was used to verify data normality. Two-way repeated-measures ANOVA were used to evaluate PRE–POST and contraction intensity changes for MEP and CSP elicited by optimal-intensity TMS. When the ANOVA revealed significant interactions, the Newman–Keuls post hoc test was used to identify differences. Paired t-tests were used to evaluate differences between PRE and POST for all other variables. The relationships between percentage change (Δ) PRE–POST in selected central and peripheral parameters were determined by Pearson product correlation. Statistical significance was set at P < 0.05. All data are presented as mean ± SD.
Subjects completed the 110-km ultratrail in a mean time of 20:17:04 ± 3:25:41 (range = 13:49:31–25:49:23), equivalent to 192% ± 33% of the overall winning time (range = 131%–245%).
Maximal voluntary torque and evoked responses
One subject with very large central deficit was an outlier and excluded from MVC and VA analyses only. There was a significant 34% decrease in MVC postrace (T23 = 7.58, P < 0.001; Fig. 2). Peripheral potentiated twitch and doublet amplitudes decreased significantly by 11% and 10%, respectively (TwPot: T24 = 3.14, P = 0.004; Db100: T24 = 4.45, P < 0.001; Fig. 2).
M-waves and RMS
M-wave amplitudes were unchanged, although there was a tendency for both Mmax and Msup to be smaller POST (Table 1). Peak-to-peak M-wave duration was also unchanged (Table 1). RMSMVC, both raw and normalized, significantly decreased from PRE to POST (Table 1).
There was a mean decrease of 16% for VATMS (93% ± 7% to 80% ± 11%, T23 = 6.91, P < 0.001) and 26% for VAFNES (91% ± 8% to 72% ± 14%, T23 = 7.64, P < 0.001). There was a correlation between ΔVAFNES and ΔVATMS (r = 0.54, P = 0.007; Fig. 3). ΔVATMS and ΔVAFNES were correlated with ΔMVC (r = 0.61, P = 0.002 and r = 0.79, P < 0.001, respectively). ΔVATMS was also correlated with ΔTwPot (r = 0.53, P = 0.008), and there was a trend for ΔVATMS to be correlated with ΔDb100 (r = 0.37, P = 0.074; see Figure, Supplemental Digital Content 3, https://links.lww.com/MSS/A394). There were no significant correlations between ΔVAFNES and peripheral changes.
There was an increase in MEP·Msup−1 elicited by optimal TMS intensity from PRE to POST (F1,24 = 11.2, P = 0.003). There was also an intensity effect (F2,48 = 32.1, P < 0.001) and time–intensity interaction (F2,48 = 6.85, P = 0.002). Post hoc analyses identified that MEP·Msup−1 was greater at 50% and 75% MVC than at 100% MVC and that at all contraction intensities MEP·Msup−1 increased from PRE to POST (P < 0.05; Fig. 4A; see Figure, Supplemental Digital Content 2, https://links.lww.com/MSS/A393). Conversely, the amplitude of MEP elicited at suboptimal TMS intensity was unchanged (T23 = 0.548, P = 0.59; Fig. 4A).
There were no changes in CSP during contractions at 50%, 75%, or 100% MVC elicited by optimal TMS intensity from PRE to POST (F1,21 = 0.0024, P = 0.96) or time–intensity interaction (F2,42 = 2.20, P = 0.12) (Fig. 4B; see Figure, Supplemental Digital Content 2, https://links.lww.com/MSS/A393). A contraction intensity effect presented (F2,42 = 16.37, P < 0.001) and the post hoc analyses indicate that CSP at 100% MVC were longer than CSP at 50% and 75% MVC. Conversely, CSP elicited by suboptimal stimulus intensity at 50% MVC increased in duration from PRE to POST (T20 = 2.61, P = 0.017; Fig. 4B). At suboptimal TMS intensity, no CSP was elicited in at least one contraction in five subjects PRE and in one subject POST due to the stimulus intensity being insufficient.
Central fatigue has been reported to be the main cause of knee extensor strength loss after prolonged running (25,29,31). The primary aim of the present study was to determine whether at least part of this central fatigue was supraspinal. The main results are that after a 110-km ultratrail, (i) there were significant and correlated decreases in VATMS and VAFNES; (ii) there were correlations between peripheral changes and decreases in VATMS, suggesting that the large central deficits consistently observed after extreme duration running exercise have both central and peripheral origins; and (iii) there was increased corticospinal excitability (as indicated by greater VL MEP amplitude) and no change in intracortical inhibition (as indicated by unchanged VL CSP) at optimal TMS intensity. There was also increased CSP duration and unchanged MEP amplitude at suboptimal TMS intensity. These suggest that during contractions at 50% MVC, there is a shift in the VL MEP–stimulus intensity relationship toward larger MEP amplitudes only at higher TMS intensities and that there is also a left shift in the VL CSP–stimulus intensity relationship.
Maximal torque and FNES measures: comparison with the literature
Only a couple studies (25,33,40) have examined long-distance running comparable with that of the ultratrail in the present study. Despite being of shorter duration than these studies, the mean MVC decrease was similar (25,33) or greater (40) after a similar delay to postexercise evaluation (40–60 min) (33,40), a finding compatible with the existence of a plateau in the strength loss–exercise duration relationship (29). In this study, ΔVAFNES was comparable with that reported after a 24-h treadmill run (25), a 330-km ultratrail (mean time ∼122.5 h) with 24 000 m of elevation change (40), and a 166-km ultratrail (mean time ∼37.5 h) with 9500 m of elevation change (33). The latter study reported decreased VL M-wave amplitude and increased VL M-wave duration. A similar tendency for Mmax and Msup amplitude and Msup duration was observed in the present study. Finally, as with longer treadmill and ultratrail runs (25,33,40), potentiated twitch amplitude in the present study decreased, although to a lesser extent than that in previous studies. With shorter trail (mean time < 9 h) and treadmill runs (mean time < 3.5 h), a change in twitch amplitude PRE to POST was not observed (7,31,32,38,39), suggesting an effect of distance and/or duration on twitch amplitude. The present results confirm previously published consequences of extreme running exercise on both central and peripheral fatigue.
Voluntary activation assessed by TMS and FNES
This study was the first to measure VATMS of the knee extensors with fatigue induced by long-distance running. Previously, Ross et al. (39) observed decreased dorsiflexor VATMS after a 42.2-km treadmill marathon, but dorsiflexors are not considered limiting to trail running performance (8). All other investigations of knee extensor VATMS have been conducted with cycling, and all showed decreased VATMS after exercise (11,43,50), except the study of Klass et al. (21), where no decrease in VATMS was observed 10 min after ∼1.5 h of cycling.
In the present study, despite greater ΔVAFNES than ΔVATMS (−26% vs −16%), these changes were well correlated, indicating that supraspinal fatigue plays an important role in the decrease of VAFNES. The greater decrease in central fatigue assessed by FNES than TMS has been previously observed by our group (50) and suggests that VAFNES comprises both fatigue manifesting at the cortical and spinal levels while VATMS is representative of central fatigue only at the supraspinal level. This finding is however in contrast to previous cycling studies that have observed greater maximal force loss linked to VATMS (43) or no difference between methods of VA determination (21). Caution must also be taken when comparing these methods due to differences in torque–SIT relationships (i.e., linear at contraction intensities ≥50% MVC for VATMS [12,42] and nonlinear at near-maximal contraction intensities ) and the precise mechanisms evaluated by each method (for an explanation of differences between VATMS and VAFNES, see Introduction). The correlation between ΔVAFNES in knee extensors and plantar flexors previously observed in an ultratrail (33) suggests there is one or more common regulatory components independent of peripheral factors that contribute to decreased VA. Candidates include hypoglycemia (3), cerebral catecholamine concentrations (15), core temperature (36), cerebral ammonia accumulation (35), and brain neurotransmitters (26), all of which are involved in brain signaling or have a demonstrated link to the development of fatigue.
Conversely, there are significant correlations between ΔVATMS, but not ΔVAFNES, and peripheral factors (ΔTwPot and ΔDb) in the present study. Fatigue is multifactorial, and despite the significant correlations between VATMS and peripheral changes, some are weak (see Figure, Supplemental Digital Content 3, https://links.lww.com/MSS/A394). Collectively, these correlations cannot explain an important portion of the observed fatigue, indicating that factors not investigated in the present study play an important role in the development of fatigue. The observed correlations also suggest that afferent feedback from the muscle is involved in central fatigue observed after an ultratrail and that information communicated from the evaluated muscles via type III and IV afferents is integrated at the supraspinal level. This idea has previously been proposed for shorter endurance cycling exercise (1). Recently, elbow extensor fatigue was observed to induce central deficits in the elbow flexor due to afferent feedback (19), suggesting that knee flexor fatigue may have also contributed to the decreased VA observed after an ultratrail in the present study. Previous research also suggests that neither acidosis nor potassium are major factors in ultraendurance activities (33), indicating that group III and group IV afferents likely respond to mechanical stimuli (i.e., stress and pressure) (10,23) and inflammatory processes (16,41) in this type of event. After extreme endurance activities, inflammatory markers remain elevated up to 5 d after the cessation of the exercise bout (33,34), well beyond the 1-h delay to POST testing in the present study. Meanwhile, the lack of correlation between ΔVAFNES and peripheral factors suggests that other factors, perhaps reduced spinal excitation/increased spinal inhibition by Ia and Ib afferents, are integrated to cause fatigue at the spinal level. The specific role of peripheral muscle afferents and direct spinal and supraspinal mechanisms remains to be determined.
MEP and CSP
The TMS contraction series required maximal (100% MVC) and submaximal (50% and 75% MVC) isometric contractions. Increased MEP amplitude and unchanged CSP at optimal TMS intensity in the VL after the ultratrail could indicate a transient increase in corticospinal excitability without change in intracortical inhibition that translates into a more effective corticospinal response to a given stimulus.
Previous studies from other laboratories have not shown any change in MEP amplitude/area or CSP duration after cycling (intensity = 55%–80% maximal power output, mean duration = 4–94 min) (11,21,43) when investigated in a similar manner. These results contrast those observed in the present study. Two factors, exercise duration and TMS intensity, may contribute to these differences. Another study from our group observed MEP amplitude in the VL and vastus medialis to increase during 40 min of cycling at 65% maximal aerobic power output followed by an incremental cycling test to task failure (50). MEP amplitude also increased at optimal TMS intensity in the present study, after a more extreme activity in terms of duration. Together, these studies suggest that the duration of effort and the associated consequences (e.g., hydration, glycemia, pain, and also sleep deprivation for extreme-duration exercise) play an important role in transient changes toward higher corticospinal excitability when tested at optimal TMS intensity (66% ± 9% maximal stimulator output). The concurrent use of optimal and suboptimal TMS intensities to evaluate MEP and CSP changes is novel, and our results suggest that selection of an appropriate TMS intensity is essential. Both Klass et al. (21) and Sidhu et al. (43) performed TMS at intensities comparable with suboptimal TMS intensities in the present study (i.e., 30%–60% maximal stimulator output vs 40% ± 5% maximal stimulator output in the present study). At suboptimal TMS intensity, the unchanged MEP amplitudes in the present study mirrored the aforementioned findings of these studies (21,43). Furthermore, Sidhu et al. (44) found no change in MEP amplitude normalized to Msup at similar TMS intensities (i.e., 41.4% ± 0.9% maximal stimulator output) during a cycling bout in the only truly sport-specific TMS investigation. Unlike the observed increase in CSP at suboptimal TMS intensity in the present study, other studies of total duration from ∼45 to 90 min (21,43) did not observe a change in CSP despite similar mean CSP durations and TMS intensities. This supports the proposal that corticospinal changes are related to exercise duration. The finding that increased corticospinal inhibition occurs during exercise at suboptimal TMS intensity has previously been observed during cycling using a different method of evaluation (45).
Although the contraction mode is different from the stretch–shortening cycle observed during running, among the isometric voluntary contractions evaluated in the present study, those at 50% MVC with suboptimal-intensity TMS would probably be the contractions most similar to conditions during an ultratrail because maximal physical efforts are rare and there are many diverse mental demands during this type of effort (29). Unlike the unchanged CSP and increased MEP amplitude at optimal TMS intensity, CSP induced by TMS at suboptimal intensity increased in duration while MEP amplitude remained unchanged. These results can be placed within the framework of the previously demonstrated sigmoidal MEP–stimulus intensity (4,6) and CSP–stimulus intensity (6,20) relationships. In the present study, optimal TMS intensity was determined as the lowest stimulus intensity eliciting a maximal MEP response (i.e., the intensity at the start of the plateau in an MEP–stimulus intensity curve) at 20% MVC. The observed changes in MEP amplitude and CSP duration suggest that if both MEP and CSP stimulus–response curves had been performed at 50% MVC, they would have undergone transformations and/or shifts but that these changes would have been different (Fig. 5). It is proposed that after ultraendurance running exercise, there would be a shift of the MEP stimulus– response curve toward greater MEP amplitudes at higher TMS intensities without change in the lower inflection point (Fig. 5A). Concurrently, it is proposed that there would be a left shift of the CSP stimulus–response curve (Fig. 5B). This suggests that an ultratrail may cause a decrease in the threshold to induce CSP during contractions at 50% MVC at a suboptimal TMS intensity. The functional relevance of these shifts remain to be elucidated; however, they suggest that the delivery of TMS at an intensity to elicit a maximal response is supraphysiological and perhaps less relevant to the normal functioning of the human body than a stimulus intensity that corresponds to the rising part of a stimulus–response curve. These shifts also suggest that the role of intracortical inhibition may increase with increasing exercise duration and may have a role in the performance deficits exhibited after prolonged exercise.
Subjects were tested as soon as possible after they completed the ultratrail competition. Despite efforts to conduct POST measures in a timely manner, there was a large delay (1:01:30 ± 0:22:37) and some variability in the time between race completion and the start of testing because of the distance from the finish to the testing site and the necessity of ensuring the safety of the subjects. The same coil position and TMS stimulus intensity were used at PRE and POST. This was performed for several reasons: (i) given the physical state of the subjects at POST, including several that were unable to complete the three series of contractions with TMS, the reassessment of TMS intensity before POST assessment would probably have reduced the number of subjects and affected data analysis; and (ii) to be able to compare CSP and MEP because changes to stimulus intensity influence both these parameters. Optimal stimulus intensity was similar PRE and POST. Because of the delay in conducting POST, the magnitude of voluntary activation decreases may be underestimated, and MEP and CSP changes may be underestimated or masked. Previous studies have shown MEP and CSP to recover rapidly after isometric single-joint exercise (e.g., 48,49). Because of the nature of the ultratrail, it was impossible to test subjects at the same time of day. Nevertheless, this was unlikely to influence results as corticospinal and intracortical excitability have been shown to be unaffected by time of day (5). Because this study was conducted in conjunction with an existing ultratrail, there was no control over the part of the menstrual cycle of the female subjects. Although hormonal changes during the menstrual cycle may have influenced the results (46,47), the random distribution of women across their cycles would probably have nullified any effects. Furthermore, in isometric contraction protocols, neither the time to task failure (18) nor the decrease in maximal voluntary force (17) were influenced by the timing of the menstrual cycle, and supraspinal deficits with exercise were observed to be similar between men and women (17,18). Finally, antagonist (e.g., biceps femoris) EMG was not measured because of time constraints. Changes in the relative contribution of agonists and antagonists may affect measures such as VA.
This study was the first to combine TMS and extreme endurance to investigate the physiological consequences of an extreme duration exercise on central changes at the supraspinal level. The hypotheses that an ultratrail decreases VATMS and that corticospinal fatigue occurs with a concomitant increase in MEP amplitude and unchanged CSP duration were confirmed. However, CSP induced by suboptimal TMS intensity increased without concurrent change in MEP amplitude at this intensity. This suggests a left shift in the CSP–stimulus intensity relationship and a shift in the MEP–stimulus intensity relationship toward larger MEP at higher TMS intensities without change in the inflection point of the curve.
The authors gratefully thank all the ultratrail competitors that participated in this study for the generous contribution of their time. They sincerely acknowledge the organizers and medical commission of the North Face® Ultra-Trail du Mont-Blanc® 2012, the financial support of the Institut Fédératif de Recherche en Sciences et Ingénierie de la Santé, and also the assistance of Dr. Roger Ouillon and Dr. Pascal Edouard for conducting medical inclusions, Philippe Gimenez and Marlène Giandolini for conducting V˙O2max tests, and Régis Bonnefoy and Rodolphe Testa for technical support. John Temesi was supported by a doctoral research grant from the Rhône-Alpes Region.
The authors declare no conflicts of interest.
The results of this study do not constitute an endorsement by the American College of Sports Medicine.
1. Amann M. Central and peripheral fatigue: interaction during cycling exercise in humans. Med Sci Sports Exerc
. 2011; 43 (11): 2039–45.
2. Bigland-Ritchie B, Woods JJ. Changes in muscle contractile properties and neural control during human muscular fatigue. Muscle Nerve
. 1984; 7 (9): 691–9.
3. Davis JM, Bailey SP. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc
. 1997; 29 (1): 45–57.
4. Devanne H, Lavoie BA, Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res
. 1997; 114 (2): 329–38.
5. Doeltgen SH, Ridding MC. Behavioural exposure and sleep do not modify corticospinal and intracortical excitability in the human motor system. Clin Neurophysiol
. 2010; 121 (3): 448–52.
6. Duclay J, Pasquet B, Martin A, Duchateau J. Specific modulation of corticospinal and spinal excitabilities during maximal voluntary isometric, shortening and lengthening contractions in synergist muscles. J Physiol
. 2011; 589 (Pt 11): 2901–16.
7. Easthope CS, Hausswirth C, Louis J, Lepers R, Vercruyssen F, Brisswalter J. Effects of a trail running competition on muscular performance and efficiency in well-trained young and master athletes. Eur J Appl Physiol
. 2010; 110 (6): 1107–16.
8. Fourchet F, Millet GP, Tomazin K, et al. Effects of a 5-h hilly running on ankle plantar and dorsal flexor force and fatigability. Eur J Appl Physiol
. 2012; 112 (7): 2645–52.
9. Gandevia SC, Allen GM, Butler JE, Taylor JL. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol
. 1996; 490: 529–36.
10. Ge W, Khalsa PS. Encoding of compressive stress during indentation by group III and IV muscle mechano-nociceptors in rat gracilis muscle. J Neurophysiol
. 2003; 89 (2): 785–92.
11. Goodall S, Gonzalez-Alonso J, Ali L, Ross EZ, Romer LM. Supraspinal fatigue after normoxic and hypoxic exercise in humans. J Physiol
. 2012; 590 (Pt 11): 2767–82.
12. Goodall S, Romer LM, Ross EZ. Voluntary activation of human knee extensors measured using transcranial magnetic stimulation. Exp Physiol
. 2009; 94 (9): 995–1004.
13. Groppa S, Oliviero A, Eisen A, et al. A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol
. 2012; 123 (5): 858–82.
14. Gruet M, Temesi J, Rupp T, Levy P, Millet GY, Verges S. Stimulation of the motor cortex and corticospinal tract to assess human muscle fatigue. Neuroscience
. 2013; 231: 384–99.
15. Hasegawa H, Piacentini MF, Sarre S, Michotte Y, Ishiwata T, Meeusen R. Influence of brain catecholamines on the development of fatigue in exercising rats in the heat. J Physiol
. 2008; 586 (1): 141–9.
16. Hoheisel U, Unger T, Mense S. Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain
. 2005; 114 (1–2): 168–76.
17. Hunter SK, Butler JE, Todd G, Gandevia SC, Taylor JL. Supraspinal fatigue does not explain the sex difference in muscle fatigue of maximal contractions. J Appl Physiol
. 2006; 101 (4): 1036–44.
18. Keller ML, Pruse J, Yoon T, Schlinder-Delap B, Harkins A, Hunter SK. Supraspinal fatigue is similar in men and women for a low-force fatiguing contraction. Med Sci Sports Exerc
. 2011; 43 (10): 1873–83.
19. Kennedy DS, McNeil CJ, Gandevia SC, Taylor JL. Firing of antagonist small-diameter muscle afferents reduces voluntary activation and torque of elbow flexors. J Physiol
. 2013; 591 (Pt 14): 3591–604.
20. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Kazis A, Mills KR. Silent period to transcranial magnetic stimulation: construction and properties of stimulus–response curves in healthy volunteers. Exp Brain Res
. 2005; 163 (1): 21–31.
21. Klass M, Roelands B, Levenez M, et al. Effects of noradrenaline and dopamine on supraspinal fatigue in well-trained men. Med Sci Sports Exerc
. 2012; 44 (12): 2299–308.
22. Kooistra RD, de Ruiter CJ, de Haan A. Conventionally assessed voluntary activation does not represent relative voluntary torque production. Eur J Appl Physiol
. 2007; 100 (3): 309–20.
23. Legramante JM, Raimondi G, Adreani CM, et al. Group III muscle afferents evoke reflex depressor responses to repetitive muscle contractions in rabbits. Am J Physiol Heart Circ Physiol
. 2000; 278 (3): H871–7.
24. Lepers R, Maffiuletti NA, Rochette L, Brugniaux J, Millet GY. Neuromuscular fatigue
during a long-duration cycling exercise. J Appl Physiol
. 2002; 92 (4): 1487–93.
25. Martin V, Kerherve H, Messonnier LA, et al. Central and peripheral contributions to neuromuscular fatigue
induced by a 24-h treadmill run. J Appl Physiol
. 2010; 108 (5): 1224–33.
26. Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF. Central fatigue: the serotonin hypothesis and beyond. Sports Med
. 2006; 36 (10): 881–909.
27. Merton PA. Voluntary strength and fatigue. J Physiol
. 1954; 123 (3): 553–64.
28. Millet GP, Millet GY. Ultramarathon is an outstanding model for the study of adaptive responses to extreme load and stress. BMC Med
. 2012; 10: 77.
29. Millet GY. Can neuromuscular fatigue
explain running strategies and performance in ultra-marathons?: the flush model. Sports Med
. 2011; 41 (6): 489–506.
30. Millet GY, Lepers R. Alterations of neuromuscular function after prolonged running, cycling and skiing exercises. Sports Med
. 2004; 34 (2): 105–16.
31. Millet GY, Lepers R, Maffiuletti NA, Babault N, Martin V, Lattier G. Alterations of neuromuscular function after an ultramarathon. J Appl Physiol
. 2002; 92 (2): 486–92.
32. Millet GY, Martin V, Lattier G, Ballay Y. Mechanisms contributing to knee extensor strength loss after prolonged running exercise. J Appl Physiol
. 2003; 94 (1): 193–8.
33. Millet GY, Tomazin K, Verges S, et al. Neuromuscular consequences of an extreme mountain ultra-marathon. PLoS One
. 2011; 6 (2): e17059.
34. Neubauer O, Konig D, Wagner KH. Recovery after an Ironman triathlon: sustained inflammatory responses and muscular stress. Eur J Appl Physiol
. 2008; 104 (3): 417–26.
35. Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol
. 2005; 563 (Pt 1): 285–90.
36. Nybo L, Nielsen B. Hyperthermia and central fatigue during prolonged exercise in humans. J Appl Physiol
. 2001; 91 (3): 1055–60.
37. Place N, Lepers R, Deley G, Millet GY. Time course of neuromuscular alterations during a prolonged running exercise. Med Sci Sports Exerc
. 2004; 36 (8): 1347–56.
38. Ross EZ, Goodall S, Stevens A, Harris I. Time course of neuromuscular changes during running in well-trained subjects. Med Sci Sports Exerc
. 2010; 42 (6): 1184–90.
39. Ross EZ, Middleton N, Shave R, George K, Nowicky A. Corticomotor excitability contributes to neuromuscular fatigue
following marathon running in man. Exp Physiol
. 2007; 92 (2): 417–26.
40. Saugy J, Place N, Millet GY, Degache F, Schena F, Millet GP. Alterations of neuromuscular function after the world’s most challenging mountain ultra-marathon. PLoS One
. 2013; 8 (6): e65596.
41. Schomburg ED, Steffens H, Dibaj P, Sears TA. Major contribution of Aδ-fibres to increased reflex transmission in the feline spinal cord during acute muscle inflammation. Neurosci Res
. 2012; 72 (2): 155–62.
42. Sidhu SK, Bentley DJ, Carroll TJ. Cortical voluntary activation of the human knee extensors can be reliably estimated using transcranial magnetic stimulation. Muscle Nerve
. 2009; 39 (2): 186–96.
43. Sidhu SK, Bentley DJ, Carroll TJ. Locomotor exercise induces long-lasting impairments in the capacity of the human motor cortex to voluntarily activate knee extensor muscles. J Appl Physiol
. 2009; 106 (2): 556–65.
44. Sidhu SK, Cresswell AG, Carroll TJ. Motor cortex excitability does not increase during sustained cycling exercise to volitional exhaustion. J Appl Physiol
. 2012; 113 (3): 401–9.
45. Sidhu SK, Lauber B, Cresswell AG, Carroll TJ. Sustained cycling exercise increases intracortical inhibition. Med Sci Sports Exerc
. 2013; 45 (4): 654–62.
46. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM. Effects of ovarian hormones on human cortical excitability. Ann Neurol
. 2002; 51 (5): 599–603.
47. Smith MJ, Keel JC, Greenberg BD, et al. Menstrual cycle effects on cortical excitability. Neurology
. 1999; 53 (9): 2069–72.
48. Taylor JL, Allen GM, Butler JE, Gandevia SC. Supraspinal fatigue during intermittent maximal voluntary contractions of the human elbow flexors. J Appl Physiol
. 2000; 89 (1): 305–13.
49. Taylor JL, Butler JE, Allen GM, Gandevia SC. Changes in motor cortical excitability during human muscle fatigue. J Physiol
. 1996; 490 (Pt 2): 519–28.
50. Temesi J, Arnal PJ, Davranche K, et al. Does central fatigue explain reduced cycling after complete sleep deprivation? Med Sci Sports Exerc
. 2013; 45 (12): 2243–53.
51. Todd G, Taylor JL, Gandevia SC. Measurement of voluntary activation of fresh and fatigued human muscles using transcranial magnetic stimulation. J Physiol
. 2003; 551 (Pt 2): 661–71.